Search Results - DURANDO, A

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

    Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study by Pant, Shubham, Schuler, Martin, Iyer, Gopa, Witt, Olaf, Doi, Toshihiko, Qin, Shukui, Tabernero, Josep, Lugowska, Iwona, Carranza, Omar, Arnold, Dirk, Gutierrez, Martin, Winter, Helen, Stuyckens, Kim, Crow, Lauren, Najmi, Saltanat, Thomas, Shibu, Santiago-Walker, Ademi, Triantos, Spyros, Sweiti, Hussein, Loriot, Yohann, Carranza, Omar, Coward, Jim, Joshua, Anthony, Karapetis, Christos, Hart, Christopher, Zhang, Alison, Prenen, Hans, Goeminne, Jean-Charles, Machiels, Jean-Pascal, Rottey, Sylvie, Corassa, Marcelo, Molin, Graziela Zibetti Dal, Tiscoski, Katsuki, Mak, Milena, Fu, Wei, Yao, Herui, Jiang, Haiping, Qin, Shukui, Chen, Baoshi, Yang, Yu, Loriot, Yohann, Le Tourneau, Christophe, Penel, Nicolas, Durando, Xavier, Emambux, Sheik, Folprecht, Gunnar, Arnold, Dirk, Schuler, Martin, Ahrens, Marit, Golf, Alexander, Haag, Georg Martin, Desuki, Alexander, Cazzaniga, Marina, Ciardiello, Fortunato, Koyama, Takafumi, Aogi, Kenjiro, Kuboki, Yasutoshi, Lee, Jungyun, Kim, Sung-Bae, Chang, Jong Hee, Kim, Yong-Man, Nam, Do-Hyun, Park, Jae-Sung, Lugowska, Iwona, Paz-Ares, Luis, Moreno, Victor, Calvo, Mariona, Falcon, Alejandro, Gonzalez, Antonio, Tabernero, Josep, Martinez Bueno, Alejandro, García-Corbacho, Javier, Chen, Jen-Shi, Hou, Ming-Feng, Chao, Yee, Rau, Kun-Ming, Chiu, Tai-Jan, Feng, Yin-Hsun, Hsu, Chih-Hung, Lai, Kuan-Ming, Yeh, Su-peng, Minchom, Anna, Welsh, Liam, Plummer, Ruth, Gutierrez, Martin, Arrowsmith, Edward, Pant, Shubham, Spigel, David Robert, Zandberg, Dan Paul, Doroshow, Deborah, Moezi, Mehdi, Paulson, Scott, Reardon, David, Ward, Patrick, Chaves, Jorge, Hussein, Atif, Manda, Sudhir, Richey, Stephen L, Tamura, David, Wilks, Sharon

    Published in The lancet oncology
    Get full text
    Article
  8. 8
  9. 9

    6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial by Kerbrat, Pierre, Fumoleau, Pierre, Jacquin, Jean-Philippe, Abadie-Lacourtoisie, Sophie, Cany, Laurent, Khayat, David, Paget-Bailly, Sophie, Demarchi, F, N'Guyen, T, Stein, U, Villanueva, C, Guimont, I, Lévy, E, Delbaldo, C, Pouessel, D, Fournel-Fédérico, C, Freyer, G, Tartas, S, Bons, F, Cuvier, C, Hajjaji, N, Capitain, O, Maillart, P, Bonnefoi, H, Durand, M, Madranges, N, Mauriac, L, Durando, X, Durieux, A, Piperno-Neumann, S, Tresca, P, Ferrant, E, Mayer, F, Vanneuville, AC, Servent, V, Guastalla, JP, Biron, P, Dupuy-Brousseau, L, Lancry, L, Trédan, O, Extra, JM, Berton-Rigaud, D, Ferrero, JM, Largillier, R, Gedoin, D, Laguerre, B, Lefeuvre, C, Vauléon, E, Tennevet, I, Mefti-Lacheraf, F, Dalenc, F, André, F, Domont, J, Ezenfis, J, Provençal, J, Bellaiche-Miccio, C, Boutan-Laroze, G, Arsène, O, Merad-Boudia, Z, Orfeuvre, H, Lamy, R, Sarda, C, Salles, B, Cauvin, I, Mangold, M, Bourcier, A, Geay, JF, ElAmarti, R, Combe, M, Dauba, J, Denizon, N, Clavreul, G, Goubely, Y, Delecroix, V, Ligeza-Poisson, V, Leyronnas, C, Teissier, E, Bernard, O, Pottier-Kyndt, V, Drony, S, Moriceau, M, Besson, D, Achille, E, Moran-Ribon, A, Moullet, I, Couderc, B, Burki, F, Schaeffer, F, Montcuquet, P, Baumont, GA, Gréget, S, Ratoanina, JL, Bonichon-Lamichhane, M, Cartron, G, Dupuis, O, Ganem, G, LeRol, A, Antoine, EC, Llory, JF, Loiseau, D

    Get full text
    Article
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20